Broholm C, Laye MJ, Brandt C, Vadalasetty R, Pilegaard H, Pedersen BK, Scheele C. LIF is a contraction-induced myokine stimulating human myocyte proliferation. J Appl Physiol 111: 251-259, 2011. First published April 28, 2011 doi:10.1152/japplphysiol.01399.2010.-The cytokine leukemia inhibitory factor (LIF) is expressed by skeletal muscle and induces proliferation of myoblasts. We hypothesized that LIF is a contraction-induced myokine functioning in an autocrine fashion to activate gene regulation of human muscle satellite cell proliferation. Skeletal muscle LIF expression, regulation, and action were examined in two models: 1) young men performing a bout of heavy resistance exercise of the quadriceps muscle and 2) cultured primary human satellite cells. Resistance exercise induced a ninefold increase in LIF mRNA content in skeletal muscle, but LIF was not detectable in plasma of the subjects. However, electrically stimulated cultured human myotubes produced and secreted LIF, suggesting that LIF is a myokine with local effects. The well established exerciseinduced signaling molecules PI3K, Akt, and mTor contributed to the regulation of LIF in cultured human myotubes as chemical inhibition of PI3K and mTor and siRNA knockdown of Akt1 were independently sufficient to downregulate LIF. Human myoblast proliferation was increased by recombinant exogenous LIF and decreased by siRNA knockdown of the endogenous LIF receptor. Finally, the transcription factors JunB and c-Myc, which promote myoblast proliferation, were induced by LIF in cultured human myotubes. Indeed, both JunB and c-Myc were also increased in skeletal muscle following resistance exercise. Our data suggest that LIF is a contraction-induced myokine, potentially acting in an autocrine or paracrine fashion to promote satellite cell proliferation. skeletal muscle; satellite cells; resistance exercise; leukemia inhibitory factor
during differentiation, skeletal muscle cells secrete hundreds of myokines, only a handful of which are known (14) . Moreover, the regulation and function of most myokines are still unknown.
We previously found that leukemia inhibitory factor (LIF) could be a myokine regulated by exercise (5) . LIF is a member of the interleukin (IL)-6 cytokine super family and is expressed by a variety of tissues, including skeletal muscle (20) . Functional studies in rodents show that LIF is involved in both muscle hypertrophy (13, 33) and muscle regeneration (16, 17, 36) . In line with this, LIF induces satellite cell proliferation (1, 32) , which is considered essential for proper muscle hypertrophy and regeneration (10) . However, the mechanism for this induction is not known. Satellite cell proliferation is a tightly regulated process involving activation of a number of transcription factors, which are sensitive to changes in cytokine and growth factor signaling (10) . The transcription factors JunB and c-Myc are both involved in satellite cell regulation (7, 18, 21) and are LIF targets in other cells (e.g., embryonic stem cells) (35) .
In the present study, we hypothesize that LIF is a contraction-induced myokine that induces satellite cell proliferation and contributes to the regulation of JunB and c-Myc expression in skeletal muscle. To address this, we investigated LIF regulation in response to resistance exercise and in response to electrical stimulation of cultured primary human myotubes. Furthermore, we assessed whether LIF was regulated by phosphatidylinositol 3-kinase (PI3K), Akt, and mTor, which are well established exercise-induced signaling molecules (3, 6, 8, 9, 11, 12) . Finally, we examined whether LIF regulated JunB and c-Myc expression in human myotubes and whether LIF induced human myoblast proliferation via the endogenous receptor for LIF.
MATERIALS AND METHODS
Subjects. Eight male subjects with a moderate active life style, not regularly enrolled in any kind of resistance training, participated in the study. The subjects had a mean Ϯ SE age, height, weight, and body mass index (BMI) of 25 Ϯ 1 yr, 186 Ϯ 2 cm, 85 Ϯ 3 kg, and 25 Ϯ 1 kg/m 2 , respectively. All subjects had a normal medical history and no physical abnormalities. The subjects were given both oral and written information about the risks and discomfort associated with the experimental protocol. The protocol was approved by the Municipal Ethical Committee for Copenhagen and Frederiksberg (KF: 01-034/ 03) and was in accordance with the Declaration of Helsinki.
Study design. All subjects performed a pretest 1-2 wk before the study to determine the workload to be used on the experimental day. The pretest was performed on a leg press and a knee extensor kicking machine, and the load was gradually increased until the subjects could only complete between six and eight repetitions. The subjects were allowed to rest between the sets to avoid muscle fatigue. The subjects were instructed not to participate in any resistance exercise 48 h before the experimental day. On the experimental day, a heavyresistance exercise protocol that stimulated the vastus lateralis muscle was used. The exercise protocol contained four sets of 6 -8, 6 -8, 10 -14, and 10 -14 repetitions and was first performed on a leg press machine and second on a knee extensor machine. The intention was to reach total exhaustion in each set. The load was adjusted during the training session so that the pre-determined repetitions could be completed. Subjects were encouraged to lower the weights slowly (the eccentric phase) and to push them up as fast as possible (the concentric phase). There was a 90-s rest period between each set and a 3-min rest period between the two machines. The complete exercise routine (a total of eight sets) was completed in ϳ20 min. Muscle biopsies were obtained from the vastus lateralis muscle using a biopsy needle with suction (2) before exercise and 6, 24, and 48 h after the end of exercise. The preexercise biopsy was obtained from the left leg, and the 6-, 24-, and 48-h biopsies were obtained from the right leg. Incisions were made 3 cm apart, and only one biopsy was obtained from each incision site. The biopsies were quickly frozen in liquid nitrogen and stored at Ϫ80°C until analyzed.
Human myocytes. Satellite cells were isolated from human skeletal muscle biopsies obtained from the vastus lateralis muscle using a biopsy needle with suction (2). The muscle cell donor subjects, which did not undergo any exercise within the last 48 h, had a mean Ϯ SE age, height, weight, and BMI of 52 Ϯ 7 yr, 181 Ϯ 32 cm, 80 Ϯ 6 kg and 24 Ϯ 1 kg/m 2 , respectively. Fat and connective tissue were removed, and the muscle tissue was minced into small pieces with sterile scissors. Subsequently, the muscle tissue was transferred to 5 ml of sterile-filtered digestion solution [HAM/10 media containing 0.05% Trypsin-EDTA, 1 mg/ml Collagenase IV, and 10 mg/ml fatty acid free bovine serum albumin (BSA)] and shaken for 5 min at 37°C. Digestion solution containing liberated satellite cells was removed and added to 2 ml of fetal bovine serum (FBS) on ice to inactivate the digesting enzymes. Additionally, 5 ml of digestion solution was added to the remaining tissue, and the procedure was repeated. Next, the mixture was spun at 800 g for 7 min, and the supernatant was removed with suction. The pellet was washed in HAM/F10 media, resuspended and preplated in a 60-mm plate with growth media 1 (HAM/F10 supplied with 20% FBS and 1% penicillin/streptomycin) for 3 h. Finally, the cell suspension was transferred to a flask coated with matrigel and incubated at 37°C, 5% CO 2. Isolated satellite cells were cultured in growth media 1 (HAM/F10 supplied with 20% FBS and 1% penicillin/streptomycin) and plated in six-well plates. Following seeding, the media was changed to growth media 2 (DMEM 1.0 g/l glucose supplied with 10% FBS and 1% penicillin/streptomycin), and the cells were grown until confluence. On the day following cell confluence, the media was changed to differentiation media (DMEM 4.5 g/l glucose supplied with 2% horse serum and 1% penicillin/streptomycin), thereby initiating fusion of myoblasts into myotubes. Cultures were fully differentiated by day 4 -6 as determined by visual confirmation of myotube formation (Ͼ3 nuclei per myotube in ϳ70% of the cells), and cell experiments were performed (siRNA and BrdU experiments were performed on different days; for details, see sections below). The cells were incubated with LY294002 (20 M) (L9908, Sigma-Aldrich), rapamycin (50 nM) (R8781, Sigma-Aldrich), or recombinant human (rh) LIF (10 ng/ml) (L5283, Sigma-Aldrich). The control cells were treated with the solution used to dissolve the treatment compounds (LY294002 and rapamycin; DMSO and rhLIF; BSA) to correct for any effect of the dissolving compounds. The concentration of LIF in the cell media was measured using a human LIF immunoassay kit (no. DLF00, R&D Systems, Minneapolis, MN).
Electrical stimulation of myotubes. Immediately before stimulation, media was refreshed in both nonstimulated and stimulated differentiated myotubes. Cells were then stimulated for 3 h (40 V, 1 ms, 1 Hz) in a six-well plate using the C-Pace EP (IonOptix, Milton, MA), and media was collected immediately following stimulation.
siRNA transfection in myoblasts and myotubes. Transfections on human myoblasts and myotubes were performed using siRNA pools consisting of four siRNA oligos specifically targeting four different sites of the target mRNAs (Akt1 and LIFR) (On Target Plus) (Dharmacon). The purpose of the siRNA pools is to use less of each oligo to minimize any off-target effects. Transfections with siRNA targeting LIFR were performed in proliferating myoblasts (at ϳ75% confluence) using 25 nM of siRNA, and transfections with siRNA targeting Akt1 were performed at day 3 of differentiation using 100 nM of siRNA. Transfections were performed using lipofectamine 2000 (Invitrogen, Taastrup, Denmark) in antibiotic-free cell culture media (see above). In the experiments for RNA harvesting, cells were grown in six-well plates and incubated for 48 h with the siRNA mix and then harvested immediately. In the experiments for cell proliferation, cells were grown in 96-well plates and incubated for 24 h with siRNA mix and bromodeoxyuridine (BrdU) and then immediately analyzed. Control cultures were similarly prepared, but without addition of any siRNA (control) or transfected with a scrambled non-specific oligonucleotide (siRNA Scr).
BrdU proliferation assay. Isolated satellite cells were cultured in growth media (HAM/F10 supplied with 20% FBS and 1% penicillin/ streptomycin), after which 50,000 cells/ml were plated in individual wells of a 96-well plate (no. 165305, Nunc, Rochester, NY). After 2 days (ϳ75% confluence), cells were incubated with BrdU (10 M) for 24 h. BrdU incorporation was measured using an ELISA reader according to the manufacturer's protocol (catalog no. 11647229001, Roche, Mannheim, Germany).
RNA isolation and quantitative real-time PCR. Total RNA was extracted from 25 mg of human muscle tissue by a modified guanidine thiocyanate (GT)-phenol-chloroform extraction method and reverse transcribed using the Superscript II RNase H Ϫ system (Invitrogen) and oligo dT as previously described (26) . Total RNA was extracted from primary cell cultures using Nucleospin RNA columns (Machinery-Nagel), according to the manufacturer's instructions, and 0.25 g of RNA was reverse transcribed using random hexamers employing a high-capacity reverse transcription kit (Applied Biosystems, Foster City, CA). Primers for amplifying gene-specific products were designed using human-specific databases (Ensembl) and Universal Probe Library (Roche Applied Science). The primers were obtained from DNA Technology (Risskov, Denmark). The primer sequences are shown in Table 1 . 18S and ␤-actin were amplified using prede- Human LIF 5=-gtccaggttgttggggaac-3= 5=-tgccaatgccctctttattc-3= Human Akt1 5=-ggtgtcagtctccgacgtg-3= 5=-gcagcacgtgtacgagaaga-3= Human JunB 5=-gctcggtttcaggagtttgt-3= 5=-atacacagctacgggatacgg-3= Human c-Myc 5=-gatccagactctgaccttttgc-3= 5=-caccagcagcgactctga-3= Human MyoD 5=-cactacagcggcgactcc-3= 5=-taggcgccttcgtagcag-3= Human p21
5=-ctcacgcaccaacgtgtaga-3= 5=-ggcatcccctacatcgaga-3= Human Myogenin 5=-gctcagctccctcaacca-3= 5=-gctgtgagagctgcattcg-3=
veloped assay reagents (Applied Biosystems). The designed primer sets were mixed with cDNA and Sybr Green PCR Master Mix (Applied Biosystems) in a total reaction volume of 10 l. The predeveloped primers (18S and ␤-actin) were mixed with cDNA and TaqMan Universal Master Mix (Applied Biosystems) in a total reaction volume of 10 l. Detection of mRNA levels was performed in triplicate using an ABI PRISM 7900 sequence detector (Applied Biosystems). Dilution series were performed for all target genes and endogenous controls to determine the amplification efficiency. To adjust for variations in the cDNA synthesis, each gene was normalized to an endogenous control (18S ribosomal RNA or ␤-actin mRNA) using the comparative (2 Ϫ⌬⌬CT ) method (19) . SDS-PAGE and Western blotting. Muscle tissue was freeze-dried and dissected free of visual blood, fat, and connective tissue. Muscle lysate was prepared by homogenizing muscle tissue in ice-cold muscle lysis buffer (0.1 M sodium phosphate, 1 g/ml pepstatin A, 1 mM NaVO 4, 1 mM NaF, pH 7.4) with phosphatase inhibitor cocktails 1 and 2 (Sigma) and complete mini protease inhibitor cocktail (Roche, Indianapolis, IN). Cells were lysed in ice-cold cell lysis buffer (20 mM Tris, 1 mM EGTA, 1 mM EDTA, 150 mM NaCl, 1 mM NaVO 4, 1% Triton, pH 7.4) with phosphatase inhibitor cocktails 1 and 2 (Sigma) and Complete mini protease inhibitor cocktail (Roche).
Lysate proteins were separated by SDS-PAGE using 4 -12% BisTris gels (Invitrogen, Taastrup, Denmark) and transferred by electrophoresis to polyvinylidene difluoride membranes (GE Healthcare, Little Chalfont, UK). The membranes were blocked for 1 h at room temperature and subsequently incubated overnight at 4°C with antibodies against LIF (AF-250-NA, R&D Systems), pAkt thr308 (no. 4056, Cell Signaling Technology), pAkt ser473 (no. 4058, Cell Signaling Technology), total Akt (no. 4685, Cell Signaling Technology), p-mTor ser2448 (no. 2971, Cell Signaling Technology), total mTor (no. 2972, Cell Signaling Technology), or ␤-actin (A3853, Sigma). Next day, the membranes were incubated for 1 h at room temperature with a horseradish peroxidase-conjugated secondary antibody (DAKO, Glostrup, Denmark). Protein bands were detected using Supersignal West Femto chemiluminescence (Pierce, Rockford, IL) and quantified using a charge-coupled device (CCD) image sensor (ChemiDocXRS, Bio-Rad) and software (Quantity One, Bio-Rad). All membranes were stained with reactive brown total protein membrane stain (Sigma) to Statistical analysis. Data are presented as means Ϯ SE. Statistical comparison of data from two experimental groups was performed using Student's t-test. Comparison of data with repeated sampling or from multiple groups was performed by one-way ANOVA with or without accounting for repeated measures. Bonferroni's post hoc test was used to locate differences found with one-way ANOVA. All comparisons were made using SAS Analyst software. A level of P Ͻ 0.05 was accepted as statistically significant.
RESULTS
Regulation of LIF by muscle contraction. LIF mRNA and protein levels were analyzed before and after ϳ20 min of heavy resistance exercise. Compared with preexercise, the level of LIF mRNA increased ninefold (P Ͻ 0.001) in muscle biopsies obtained 6 h after the exercise bout. LIF mRNA levels had returned to preexercise levels by 24 h after the exercise bout (Fig. 1A) . LIF protein expression was not significantly induced by resistance exercise (Fig. 1B) . LIF was undetectable in plasma from the subjects (data not shown), suggesting a local rather than a systemic effect of LIF in response to exercise.
To determine whether muscle cells were in fact able to secrete LIF protein, we assessed whether LIF was released from fully differentiated cultured human primary myotubes. The presence of LIF was analyzed in fresh differentiation media (0 h) and in differentiation media 1 h and 24 h after media changing (Fig. 1C) . Although the amount of LIF in the 1-h media was not significantly different from the 0-h media, the amount of LIF in the 24-h media was increased compared with both the control media (P Ͻ 0.001) and the 1-h media (P Ͻ 0.01), indicating that LIF accumulated in the media over time due to secretion from differentiated human myotubes. In line with the increased expression of LIF mRNA following resistance exercise, electrical stimulation of human myotubes resulted in a significant increase in LIF secretion relative to unstimulated control cells (P Ͻ 0.05) (Fig. 1D) . Moreover, myotubes treated with the PI3K inhibitor (LY29004) tended to decrease the secretion of LIF in the basal state (P ϭ 0.053) and significantly decreased the contraction-induced secretion of LIF (P Ͻ 0.01) (Fig. 1D) .
Akt phosphorylation after exercise and effect of Akt inhibition on LIF expression. The phosphorylation status of Akt(Thr 308 ) and Akt(Ser 473 ) was analyzed before and after ϳ20 min of heavy resistance exercise of m. quadriceps. Akt-(Thr 308 ) and Akt(Ser 473 ) phosphorylations were unaffected by exercise at the time points investigated (Fig. 2, A and B) . In cultured myotubes, LIF mRNA levels were investigated after Akt1 knockdown. As shown in Fig. 2C , Akt1 was substantially reduced following siRNA transfection (P Ͻ 0.001). The knockdown of Akt1 resulted in a modest but significant decrease of LIF mRNA expression (P Ͻ 0.05) (Fig. 2D) .
mTor phosphorylation after exercise and effect of mTor inhibition on LIF production. The phosphorylation status of mTor(Ser 2448 ) was analyzed before and after ϳ20 min of heavy resistance exercise of m. quadriceps. mTor(Ser 2448 ) phosphorylation was unaffected by exercise at the time points investigated (Fig. 3A) . In cultured myotubes, the mTor inhibitor rapamycin decreased LIF secretion (P Ͻ 0.05) (Fig. 3C) , whereas LIF mRNA was not significantly altered (Fig. 3B) .
Regulation of human myoblast proliferation by LIF signaling. We next sought to examine whether factors released during muscle contraction are themselves capable of stimulating myoblast proliferation. Myotubes established from two different individuals were electrically stimulated for 3 h (ES media A and B) or resting for 3 h (control), and the media was immediately obtained. The ES media and control media were later given to growing myoblasts (n ϭ 5), and cell proliferation was analyzed. As seen in Fig. 4A , there was an overall effect of electrical stimulation on myoblast proliferation (P Ͻ 0.05). Similarly, stimulation of myoblasts with human recombinant LIF for 24 h increased proliferation (P Ͻ 0.05) (Fig. 4B) . Interestingly, although only obtaining an ϳ50% knockdown of LIFR (P Ͻ 0.05) (Fig. 4C) , this resulted in a decrease in myoblast proliferation (P Ͻ 0.05) (Fig. 4D) , suggesting that LIF signaling regulates myoblast proliferation in an autocrine fashion.
JunB and c-myc expression after exercise and in response to LIF stimulation. JunB and c-Myc mRNA levels were analyzed before and after ϳ20 min of heavy resistance exercise of m. quadriceps. Similar to LIF, compared with preexercise, the level of JunB mRNA increased 4-fold (P Ͻ 0.01), and the level of c-Myc increased 16-fold (P Ͻ 0.001) in muscle biopsies obtained 6 h after the exercise bout. Both transcripts had returned to preexercise levels by 24 h after the exercise bout (Fig. 5, A and B) .
To study whether LIF could affect the levels of JunB and c-Myc, cultured myotubes were stimulated with recombinant human LIF for 1 h. Compared with control cells, LIF-stimulated cells increased the mRNA expression of JunB (P Ͻ 0.05) Fig. 3 . mTor phosphorylation after exercise and effect of mTor inhibition on LIF production. A: muscle biopsies were obtained from m. vastus lateralis before (pre) and after (6, 24 , and 48 h) one bout of resistance exercise. Representative blots for phospho mTor (Ser2448) and total mTor protein expression are shown. B and C: LIF mRNA levels (B) and LIF protein secretion (C) were analyzed in myotubes treated with rapamycin for 4 h. LIF mRNA levels were related to 18S RNA levels. Data are means Ϯ SE [n ϭ 6 (A);and c-Myc (P Ͻ 0.05) (Fig. 5, C and D) . LIF treatment did not affect the mRNA expression of p21, MyoD, or Myogenin (data not shown).
DISCUSSION
In the present study, we show that LIF mRNA is induced in human skeletal muscle following resistance exercise and that LIF protein is secreted from electrically stimulated cultured myotubes. We further demonstrate that LIF stimulates proliferation of human myoblasts and induces expression of JunB and c-Myc in human myotubes, whereas siRNA knockdown of LIFR results in a reduction of proliferation. Hence, our data suggest that LIF is a myokine acting in muscle in an autocrine or paracrine fashion, with a potential role in adaptive responses to resistance exercise.
LIF is a contraction-induced myokine. In the present study, a heavy resistance exercise protocol, capable of stimulating skeletal muscle hypertrophy, induced the expression of LIF mRNA. This observation is in accordance with previous studies in rodents reporting a relation between increased LIF and skeletal muscle growth (13, 28, 33) . In addition, the finding that LIF was released from electrically stimulated myotubes in culture indicates that LIF is a contraction-regulated myokine. Nonetheless, resistance exercise did not significantly increase LIF protein expression in parallel with the increase in mRNA.
This may be due to a low subject number (n ϭ 6), but most likely it reflects the time points included in the statistic model. Indeed, a paired t-test comparing preexercise values with the 6-h postexercise values gives a significant difference (P Ͻ 0.05). Thus LIF protein may slightly increase with exercise. However, an increased LIF protein expression within muscle biopsies may be difficult to detect due to rapid turnover of LIF protein. For example, pharmakinetic analyses show that clearance of LIF is extremely rapid and that the predominant clearance pathway is high-affinity binding of LIF to specific cell surface receptors followed by endocytosis and degradation (30) . The lack of LIF in the circulation suggests that LIF acts in an autocrine and/or paracrine fashion.
PI3K, Akt1, and mTor regulate LIF expression in human myotubes. One of the key molecules regulating skeletal muscle hypertrophic growth is the PI3K, which is upstream of both the Akt and mTor pathways (3) . The present finding that inhibition of PI3K results in decreased LIF secretion in electrically stimulated myotubes suggests that a PI3K-regulated pathway contributes to increase LIF production in skeletal muscle during exercise. Moreover, our results indicate that both Akt1 and mTor are sufficient to regulate LIF.
In the resistance-exercised quadriceps muscle, both phosphorylation of Akt and mTor were unaltered. This may be explained by the relatively late postexercise biopsy sampling Fig. 4 . Regulation of human myoblast proliferation by LIF signaling. A: myotubes established from two different individuals were electrically stimulated for 3 h (ES media) or resting for 3 h (control), and the media was immediately obtained. The ES media and control media were later given to growing myoblasts (n ϭ 5), and cell proliferation was analyzed. B: cell proliferation was analyzed in myoblasts stimulated with human recombinant LIF for 24 h. C: LIFR mRNA levels were analyzed in growing myoblasts after 48-h siRNA knockdown of LIFR. LIFR mRNA levels were related to 18S RNA levels. D: cell proliferation was analyzed in growing myoblasts after 24-h siRNA knockdown of LIFR. Data are means Ϯ SE (n ϭ 3-5). *Significant difference by Student's paired t-test (control vs. LIFR siRNA; P Ͻ 0.05). (6, 24 , and 48 h) and mixed fiber-type material (quadriceps). For instance, mTor phophorylation is induced a few minutes after exercise (4) and is preferentially located in type 2 fibers (23), and Akt phosphorylations induced by resistance exercise decline rapidly (8) . Furthermore, at 6 h postexercise, LIF mRNA was significantly increased, suggesting that upstream signaling through Akt and mTor had already occurred.
Together, our studies suggest that the signaling molecules PI3K, Akt1, and mTor are involved in the regulation of LIF in myotubes. However, we believe that other pathways contribute to this regulation. For example, we previously demonstrated that the calcium ionophor, ionomycin, increased LIF expression in cultured human myotubes (5) . Thus the production of LIF may likely depend on the simultaneous activation of different pathways activated during or after exercise.
LIF stimulates myoblast proliferation. Muscle hypertrophy and regeneration depend on the addition of new myonuclei by activation, proliferation, and fusion of satellite cells to the adult muscle fibers (10, 22) . Factors released from muscle itself have been shown to increase satellite cell proliferation (31) . Here, we show that the pool of factors secreted from electrically stimulated myotubes increases myoblast proliferation. Since LIF increases myoblast proliferation, one of these factors could be LIF. Our finding that LIF induces human myoblast proliferation is in line with previous studies demonstrating an important role of LIF in cell proliferation (15, 32, 34) . Indeed, LIF is essential for maintaining embryonic stem cells in a proliferative state (35) and induces proliferation of mouse and rat myoblasts (32, 34) . In the present study, we also show that siRNA knockdown of the LIFR decreased myoblast proliferation, thereby demonstrating that signaling through the LIFR is necessary for myoblast proliferation. This finding supports our hypothesis that LIF acts in an autocrine or paracrine fashion within the muscle. The process of proliferation of myoblasts is complex but is in part controlled by the transcription factors JunB and c-Myc, which appear to promote myoblast growth and proliferation while inhibiting myogenic differentiation (7, 18, 21) . LIF is sufficient to increase expression of JunB and c-Myc in cultured human myotubes suggesting a pathway by which LIF increases proliferation. In agreement, we found that both JunB and c-Myc mRNA were highly upregulated in skeletal muscle 6 h after resistance exercise, supporting the possibility that they may play a role in regulating hypertrophy. Interestingly, the expression of JunB and c-Myc were several fold higher in human muscle following resistance exercise than after LIF stimulation of myotubes, thereby suggesting that other factors contribute to their increased expression. It is also possible that expression of LIF, JunB, and c-Myc is unrelated and that they simply increase in parallel. Nonetheless, the possibility exists that one function of muscle-derived LIF is to help increase JunB and c-Myc and thereby stimulate proliferation of satellite cells.
In conclusion, in the present study, we show that LIF is produced by contracting myotubes in a PI3K-dependent manner. Secreted LIF stimulates myoblast proliferation via LIFR and induces expression of JunB and c-Myc. Taken together, our data suggest that LIF may be produced by a contracting muscle to stimulate satellite cell proliferation. Knowledge about the regulation and function of LIF in human skeletal muscle may carry potential significance in the search for muscle atrophy therapies and may strengthen the argument that resistance exercise itself constitutes an effective therapy in the treatment of muscle atrophy.
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